Shareholding disclosure

Michel Willy c/o Techpharma Management AG

Declared position

71.1%

Threshold

Crossed upwards

Timeline

Published

21.09.2004

Transaction

—

Voting rights breakdown

Voting rights acquired71.1%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T2792D2764

Beneficial owner

Michel Willy c/o Techpharma Management AG

Declared address

Michel Willy c/o Techpharma Management AG, Burgdorf

21.09.2004; Kotierungsprospekt

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Michel Willy c/o Techpharma Management AG

Ypsomed Holding AG21.09.2004T2792D2764

Disclosure summary

Michel Willy c/o Techpharma Management AG disclosed a holding in Ypsomed Holding AG on the acquisition side, published by SIX Exchange Regulation on 21.09.2004, at 71.1% of voting rights. Notice category: Group of shareholders.

Disclosed position

71.1%

Voting rights acquired

Voting rights acquired71.1%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Michel Willy c/o Techpharma Management AG disclosed a holding in Ypsomed Holding AG, published on 21.09.2004.

Publication date21.09.2004

Issuing companyYpsomed Holding AG

Beneficial ownerMichel Willy c/o Techpharma Management AG

Declared addressMichel Willy c/o Techpharma Management AG, Burgdorf

CategoryGroup of shareholders

Voting rights acquired71.1%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT2792D2764

Conditions

21.09.2004; Kotierungsprospekt

Source: SIX Exchange Regulation · Publication date: 21.09.2004

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open